- Home
- NEXN vs SOPH Comparison
NEXN vs SOPH Comparison
Compare NEXN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEXN | SOPH |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | Israel | Switzerland |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.5M | 462.3M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NEXN | SOPH |
|---|---|---|
| Price | $8.86 | $6.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $14.64 | $9.75 |
| AVG Volume (30 Days) | 329.7K | ★ 600.0K |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.10 | $23.24 |
| Revenue Next Year | $8.88 | $24.63 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.60 | $3.75 |
| 52 Week High | $11.30 | $8.98 |
Technical Indicators
Market Signals| Indicator | NEXN | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 35.65 |
| Support Level | $8.57 | $4.58 |
| Resistance Level | $9.07 | $8.80 |
| Average True Range (ATR) | 0.27 | 0.51 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 37.93 | 2.65 |
Price Performance
Historical ComparisonAbout NEXN Nexxen International Ltd. American Depository Shares
Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and TV that helps empower advertisers, agencies, digital publishers, broadcasters, and others. The Digital Advertising Ecosystem of the company includes demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. The company operates in America, APAC, EMEA, and Rest of America, with majority revenue from United States.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.